Viewing Study NCT06203132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:26 PM
Ignite Modification Date: 2026-02-01 @ 1:51 PM
Study NCT ID: NCT06203132
Status: RECRUITING
Last Update Posted: 2025-12-16
First Post: 2023-12-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection
Sponsor: ANRS, Emerging Infectious Diseases
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV-1-infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV-1 View
None ART-naïve View
None doravirine View
None dolutegravir View
None non-inferiority View